Format
Items per page
Sort by

Send to:

Choose Destination

Results: 17

Cited In for PubMed (Select 12892538)

1.

Associations between anxiety, depression, antidepressant medication, obesity and weight gain among Canadian women.

Grundy A, Cotterchio M, Kirsh VA, Kreiger N.

PLoS One. 2014 Jun 16;9(6):e99780. doi: 10.1371/journal.pone.0099780. eCollection 2014.

2.

Influence of body mass index on the choice of therapy for depression and follow-up care.

Boudreau DM, Arterburn D, Bogart A, Haneuse S, Theis MK, Westbrook E, Simon G.

Obesity (Silver Spring). 2013 Mar;21(3):E303-13. doi: 10.1002/oby.20048.

3.

Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes.

Rubin RR, Peyrot M, Gaussoin SA, Espeland MA, Williamson D, Faulconbridge LF, Wadden TA, Ewing L, Safford M, Evans-Hudnall G, Wing RR, Knowler WC; Look AHEAD Research Group.

Diabetes Care. 2013 May;36(5):1088-94. doi: 10.2337/dc12-1871. Epub 2013 Jan 28.

4.

Changes in body weight and psychotropic drugs: a systematic synthesis of the literature.

Dent R, Blackmore A, Peterson J, Habib R, Kay GP, Gervais A, Taylor V, Wells G.

PLoS One. 2012;7(6):e36889. doi: 10.1371/journal.pone.0036889. Epub 2012 Jun 15. Review.

5.

Pediatric obesity: etiology and treatment.

Crocker MK, Yanovski JA.

Pediatr Clin North Am. 2011 Oct;58(5):1217-40, xi. doi: 10.1016/j.pcl.2011.07.004. Review.

6.

Antidepressant medication use and future risk of cardiovascular disease: the Scottish Health Survey.

Hamer M, Batty GD, Seldenrijk A, Kivimaki M.

Eur Heart J. 2011 Feb;32(4):437-42. doi: 10.1093/eurheartj/ehq438. Epub 2010 Nov 30. Erratum in: Eur Heart J. 2013 Oct;34(40):3160. David Batty, G [corrected to Batty, G David].

7.

Bidirectional association between depression and type 2 diabetes mellitus in women.

Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, Willett WC, Ascherio A, Hu FB.

Arch Intern Med. 2010 Nov 22;170(21):1884-91. doi: 10.1001/archinternmed.2010.356.

8.

Anti-depressant medication use and C-reactive protein: results from two population-based studies.

Hamer M, Batty GD, Marmot MG, Singh-Manoux A, Kivimäki M.

Brain Behav Immun. 2011 Jan;25(1):168-73. doi: 10.1016/j.bbi.2010.09.013. Epub 2010 Sep 21.

9.

Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study.

Kivimäki M, Hamer M, Batty GD, Geddes JR, Tabak AG, Pentti J, Virtanen M, Vahtera J.

Diabetes Care. 2010 Dec;33(12):2611-6. doi: 10.2337/dc10-1187. Epub 2010 Sep 7.

10.

Hypertension awareness and psychological distress.

Hamer M, Batty GD, Stamatakis E, Kivimaki M.

Hypertension. 2010 Sep;56(3):547-50. doi: 10.1161/HYPERTENSIONAHA.110.153775. Epub 2010 Jul 12.

11.

Antidepressant use before and after the diagnosis of type 2 diabetes: a longitudinal modeling study.

Kivimäki M, Tabák AG, Lawlor DA, Batty GD, Singh-Manoux A, Jokela M, Virtanen M, Salo P, Oksanen T, Pentti J, Witte DR, Vahtera J.

Diabetes Care. 2010 Jul;33(7):1471-6. doi: 10.2337/dc09-2359. Epub 2010 Apr 5.

12.

Ten putative contributors to the obesity epidemic.

McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M, Benca RM, Biggio J, Boggiano MM, Eisenmann JC, Elobeid M, Fontaine KR, Gluckman P, Hanlon EC, Katzmarzyk P, Pietrobelli A, Redden DT, Ruden DM, Wang C, Waterland RA, Wright SM, Allison DB.

Crit Rev Food Sci Nutr. 2009 Nov;49(10):868-913. doi: 10.1080/10408390903372599. Review.

13.

Pediatric obesity: etiology and treatment.

Crocker MK, Yanovski JA.

Endocrinol Metab Clin North Am. 2009 Sep;38(3):525-48. doi: 10.1016/j.ecl.2009.06.007. Review.

14.
15.

Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC; Diabetes Prevention Program Research Group.

Diabetes Care. 2008 Mar;31(3):420-6. Epub 2007 Dec 10.

16.

Use of psychopharmacological agents for functional gastrointestinal disorders.

Clouse RE, Lustman PJ.

Gut. 2005 Sep;54(9):1332-41. Review. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk